Home Compliance Did the Company Violate FCA By Promoting an Off-Label Use of Botox?... ComplianceFCAResource Library Did the Company Violate FCA By Promoting an Off-Label Use of Botox? The Court Did Not Think So March 24, 2025 28 CrizzyStudio | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Government Contractors Beware: Failure to Comply with DOD Cybersecurity Requirements Can Trigger Civil FCA Liability Compliance Navigating Compliance Risks in Laboratory Operations—Key Lessons from a Recent FCA Case Compliance Sixth Circuit Affirms Post-Polansky Dismissal of FCA Action
